An Introduction to Policy
Cancer care is a challenging but fast-evolving field, and clear policies must be available for healthcare professionals, societies and patients. The European Cancer Organisation strives to bring impactful policy improvement by bringing together the oncology community and facilitating collaboration and consensus on important issues within cancer care. touchOCNOLOGY has collaborated with the European Cancer Organisation to produce video content and short articles to address the important policy issues within cancer care.
Our supporting partners do not constitute an endorsement of the content on this page.
Implementing the European Code of Cancer Practice to Improve Europe’s Cancer Outcomes
touchREVIEWS in Oncology & Haematology. 2021;17(1):Online ahead of journal publication DOI: https://doi.org/10.17925/OHR.2021.17.1.9
The European Code of Cancer Practice The European Code of Cancer Practice is a patient-centred manifesto of the key features required to deliver good clinical cancer practice and improve patient outcomes in Europe.1,2 It builds upon the European Cancer Patient’s Bill of Rights, which was launched in the European Parliament on World Cancer Day 2014 and […]
Stefan Gijssels, Eureopean Cancer Summit 2020 – The Beating Cancer Plan
touchONCOLOGY means Stefan Gijssels at the European Cancer Summit 2020 to discuss the Beating Cancer Plan and key highlights and outcomes from this year’s meeting. Questions How do you expect the cancer burden in Europe to change in the coming years? What are the aims and main components of the Beating Cancer Plan? What initiatives […]
Françoise Meunier, European Cancer Summit 2020 – Financial Toxicity and the ‘Right to be Forgotten’
Dr Françoise Meunier, Vice President of the Federation of European Academies of Medicine, joins touchONCOLOGY to discuss financial toxicity in patients with cancer and progress made with the “Right to be Forgotten” resolution made at the European Cancer Summit in 2018. Questions What does the term ‘financial toxicity’ mean, and what does it mean for […]
Daniel Kelly, European Cancer Summit 2020 – HPV Action Network
touchONCOLOGY joins Prof. Daniel Kelly to discuss the aims and scope of the European Cancer Organisation HPV Action Network. Questions What are the aims of the HPV Action Network? How can HPV-associated cancers be reduced and why is this resolution important? Could you tell us about the European Cancer Organisation’s recent action plan and report, […]
Andreas Charalambous, European Cancer Summit 2020 – Preparing a Resilient Oncology Workforce for the Present and Future
touchONCOLOGY joins Prof. Andreas Charalambous at the European Cancer Summit 2020 to discuss the work of the Workforce Network and the resolution that arose from the summit’s audience. Questions What issues does the Workforce Network aim to address? What can be done in Europe to strengthen education and training? What was the European Cancer Summit’s […]
Ana Carneiro, ESMO 2020 – Disparities in Access to Oncology Clinical Trials in Europe
At the Virtual 2020 ESMO Congress, Ana Carneiro talks about disparities in access to oncology trials from the last decade. The late-breaking abstract ‘Disparities in access to oncology clinical trials in Europe in the period 2009-2019‘ (LBA66) was presented at the Virtual 2020 ESMO Congress, 19–21 September 2020. Questions Prior to this study, what was […]
Matti Aapro – ECCO 2019 European Cancer Summit
It was an honour for touchONCOLOGY to catch up with one of our editorial board members and ECCO President-Elect Matti Aapro at the ECCO 2019 European Cancer Summit in Brussels to discuss molecular tumour diagnostics in cancer care. Questions 1. In what key areas should molecular tumour diagnostics improve cancer detection and subsequent care? (0:10) […]
Mark Lawler – ECCO 2019 European Cancer Summit
touchONCOLOGY met Professor Mark Lawler (Chair, Translational Cancer Genomics Centre for Cancer Research and Cell Biology (CCRCB), Queen’s University Belfast) at the ECCO 2019 European Cancer Summit in Brussels to discuss the EU Cancer Mission and the work of the Lancet Oncology Cancer Groundshot. Questions 1. What do the big-data, patient-centered (high-cost) research initiatives such […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!